Advanced Diagnostics for Infectious Disease - Improving Clinical Outcomes through Novel Technologies and Molecular Testing (nextgenerationdx.com)
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-838
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.1¢ | $259.2K | 11.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 7189585 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 609222 | 4 |
View Market Depth
| Last trade - 15.14pm 30/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |